AI Verdict
HQY has stronger fundamentals based on our AI analysis.
HRMY vs HQY Fundamental Comparison
| Metric | HRMY | HQY |
|---|---|---|
| Revenue | $868.5M | $1.3B |
| Net Income | $158.7M | $215.2M |
| Net Margin | 18.3% | 16.4% |
| ROE | 18.2% | 10.2% |
| ROA | 12.5% | 6.4% |
| Current Ratio | 3.60x | 3.27x |
| Debt/Equity | 0.19x | 0.45x |
| EPS | $2.71 | $2.46 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HRMY vs HQY: Frequently Asked Questions
Is HRMY or HQY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HQY has stronger fundamentals. HRMY is rated BUY (78% confidence) while HQY is rated BUY (82% confidence). This is not investment advice.
How does HRMY compare to HQY fundamentally?
Harmony Biosciences Holdings, Inc. has ROE of 18.2% vs HEALTHEQUITY, INC.'s 10.2%. Net margins are 18.3% vs 16.4% respectively.
Which stock pays higher dividends, HRMY or HQY?
HRMY has a dividend yield of N/A or no dividend while HQY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HRMY or HQY for long term?
For long-term investing, consider that HRMY has BUY rating with 78% confidence, while HQY has BUY rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HRMY vs HQY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HRMY vs HQY, the AI consensus favors HQY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.